Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model

• Published in: Cell death & disease Vol. 6; no. 6; p. e1789
• Main Authors: Kim, J A, Ha, S, Shin, K Y, Kim, S, Lee, K J, Chong, Y H, Chang, K-A, Suh, Y-H
• Format: Journal Article
• Language: English
• Published: England Springer Nature B.V 18.06.2015; Nature Publishing Group
• Subjects: Alzheimer Disease - therapy; Amyloid beta-Peptides - metabolism; Animals; Brain - surgery; Cell- and Tissue-Based Therapy - methods; Cells, Cultured; Cognition Disorders - pathology; Cognition Disorders - therapy; Cytokines - secretion; Disease Models, Animal; Maze Learning - physiology; Memory - physiology; Memory Disorders - pathology; Memory Disorders - therapy; Mice; Mice, Inbred C57BL; Neural Stem Cells - transplantation; Neurogenesis - physiology; Original
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/cddis.2015.138

Alzheimer's disease (AD) is characterized by neuronal loss in several regions of the brain. Recent studies have suggested that stem cell transplantation could serve as a potential therapeutic strategy to halt or ameliorate the inexorable disease progression. However, the optimal stage of the disease for stem cell transplantation to have a therapeutic effect has yet to be determined. Here, we demonstrated that transplantation of neural stem cells into 12-month-old Tg2576 brains markedly improved both cognitive impairments and neuropathological features by reducing β-amyloid processing and upregulating clearance of β-amyloid, secretion of anti-inflammatory cytokines, endogenous neurogenesis, as well as synapse formation. In contrast, the stem cell transplantation did not recover cognitive dysfunction and β-amyloid neuropathology in Tg2576 mice aged 15 months when the memory loss is manifest. Overall, this study underscores that stem cell therapy at optimal time frame is crucial to obtain maximal therapeutic effects that can restore functional deficits or stop the progression of AD.